Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of aripiprazole in treatment of sexual dysfunction due to antidepressants
IRCT2017020432236N5Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aripiprazole in sexual dysfunction, hypoactive sexual desire disorder (HSDD), female orgasmic disorder (FOD) and 1 more, sponsored by Mazandaran University of Medical Sciences. Started Nov 2015; status: completed.
02
Drugs
aripiprazole
03
Conditions
sexual dysfunctionhypoactive sexual desire disorder (HSDD)female orgasmic disorder (FOD)ejaculation disorders
Beyond the preview
Go deeper on IRCT2017020432236N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017020432236N5.